- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: hypersomnia.
Displaying page 1 of 1.
EudraCT Number: 2009-011302-41 | Sponsor Protocol Number: CHUBX2008/37 | Start Date*: 2009-05-15 | ||||||||||||||||
Sponsor Name:CHU de Bordeaux | ||||||||||||||||||
Full Title: METHODE D’EVALUATION DE L’APTITUDE A LA CONDUITE CHEZ DES PATIENTS SOUFFRANT DE PATHOLOGIES DE L’EVEIL AutoSoP | ||||||||||||||||||
Medical condition: Narcoleptic patients with cataplexy or hypersomniacs | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004122-15 | Sponsor Protocol Number: UF9889 | Start Date*: 2018-03-13 |
Sponsor Name:University Hospital of Montpellier | ||
Full Title: A randomized, double-blind, placebo-controlled trial comparing the efficacy and tolerance of sodium oxybate in patients affected with idiopathic hypersomnia. | ||
Medical condition: current idiopathic hypersomnia (ICSD-3) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-007033-41 | Sponsor Protocol Number: 1200 | Start Date*: Information not available in EudraCT |
Sponsor Name:Hephata-Klinik | ||
Full Title: Pilot study on therapeutic efficacy of modafinil in idiopathic hypersomnie | ||
Medical condition: To test the efficacy, tolerability and safety of modafinil for the treatment of of excessiv daytime sleepiness in patients with idiopathic hypersomnia without long sleep time. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002127-16 | Sponsor Protocol Number: UCAB-CT-03 | Start Date*: 2017-08-24 | |||||||||||
Sponsor Name:Umecrine Cognition AB | |||||||||||||
Full Title: A phase IIa study of GR3027 in patients with idiopathic hypersomnia (IH) involving an open-label part to assess safety, tolerability and pharmacokinetics (PK) of a single oral GR3027 dose in female... | |||||||||||||
Medical condition: Idiopathic hypersomnia (IH) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) DK (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001584-23 | Sponsor Protocol Number: 7605 | Start Date*: 2018-10-30 |
Sponsor Name:University Hospital of Montpellier | ||
Full Title: "Microglial Activation in Narcolepsy Type 1: Positron Emission Tomography (PET) Study in [18F] DPA-714" | ||
Medical condition: To study in vivo microglial activation by PET [18F] DPA-714 in NT1 patients with recent evolution (appearance of the first symptoms - somnolence and cataplexy-less than 2 years ago) compared with c... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001311-79 | Sponsor Protocol Number: JZP080-301 | Start Date*: 2019-01-09 | ||||||||||||||||
Sponsor Name:Jazz Pharmaceuticals | ||||||||||||||||||
Full Title: A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) with an Open-label Safety Extension | ||||||||||||||||||
Medical condition: Treatment of Idiopathic Hypersomnia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) GB (GB - no longer in EU/EEA) CZ (Completed) BE (Completed) DE (Completed) ES (Completed) FI (Completed) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-002965-13 | Sponsor Protocol Number: TAK-861-2003 | Start Date*: 2023-04-11 | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc. | |||||||||||||
Full Title: A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions | |||||||||||||
Medical condition: Narcolepsy with Cataplexy (Type 1) and Narcolepsy without Cataplexy (Type 2) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) ES (Ongoing) NL (Ongoing) SE (Ongoing) FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022648-19 | Sponsor Protocol Number: P05898 | Start Date*: 2011-11-16 | |||||||||||
Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation | |||||||||||||
Full Title: A 26-Week Open-Label, Flexible-Dose Trial of Asenapine Extension Treatment to P06107 in Pediatric Acute Manic or Mixed episodes Associated With Bipolar I Disorder | |||||||||||||
Medical condition: Acute Manic or Mixed Episodes Associated with Bipolar I Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003452-14 | Sponsor Protocol Number: SBC007C401 | Start Date*: 2023-05-02 | |||||||||||
Sponsor Name:Berlin Cures GmbH | |||||||||||||
Full Title: A prospective, double-blind, randomised, parallel group, placebo controlled, multicentre, Phase II study to investigate the efficacy, GPCR autoantibody neutralising effect, safety, and tolerability... | |||||||||||||
Medical condition: long Covid | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022744-21 | Sponsor Protocol Number: AB08003 | Start Date*: 2013-06-05 | ||||||||||||||||
Sponsor Name:AB Science | ||||||||||||||||||
Full Title: A 12-week, proof of concept prospective, randomized, double blind, phase 2a study to compare safety and efficacy of masitinib to placebo in the treatment of mood disorders in patients with antidepr... | ||||||||||||||||||
Medical condition: mood disorders associated to major depression or dysthymic disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
